Delta-9-Tetrahydroncannabinol: Clinical Trials

1 trial for Delta-9-Tetrahydroncannabinol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Delta-9-Tetrahydroncannabinol: new trials by email Literature Review of Delta-9-Tetrahydroncannabinol trials Research Report on Delta-9-Tetrahydroncannabinol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
4 mg Delta-9-THC, Placebo, 2 mg Delta-9-THC - Delta-9-Tetrahydroncannabinol, Bipolar Disorder
Phase 1TerminatedYale University22017-08-012022-01-31

Narrower conditions

Bipolar Disorder (1)

Broader conditions

Bipolar and Related Disorders (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)

Interventions

Dronabinol (1)

Sponsors

Yale University (1)

Countries

United States (1)

Top investigators

Mohini Ranganathan, MD (1)